Careers
Contact
Company
Company
Management
Board of Directors
Scientific Advisors
Technology
Technology Platform
Cancer
Infectious Diseases
Scientific Presentations
Pipeline
Pipeline
VB10.16
VB10.NEO
Others
Partnering & Investors
Partnering
Investor Relations
News & Events
News
Media
Upcoming Events
Company
Company
Management
Board of Directors
Scientific Advisors
Technology
Technology Platform
Cancer
Infectious Diseases
Scientific Presentations
Pipeline
Pipeline
VB10.16
VB10.NEO
Others
Partnering & Investors
Partnering
Investor Relations
News & Events
News
Media
Upcoming Events
PERSONALIZED CANCER NEOANTIGEN VACCINES | London, May 2018
1658
portfolio_page-template-default,single,single-portfolio_page,postid-1658,bridge-core-1.0.4,ajax_updown_fade,page_not_loaded,,qode-title-hidden,qode-child-theme-ver-,qode-theme-ver-18.2.1,qode-theme-bridge,disabled_footer_top,qode_header_in_grid,wpb-js-composer js-comp-ver-6.0.5,vc_responsive
PERSONALIZED CANCER NEOANTIGEN VACCINES
TURNING THE IMMUNE SYSTEM AGAINST YOUR OWN UNIQUE TUMOUR-SPECIFIC ANTIGENS
London, May 2018
Download presentation